
iniuva uses AI to accelerate discovery of small-molecule therapies for diseases caused by protein misfolding. It operates as an AI-powered platform for small-molecule drug discovery serving biotech and pharmaceutical companies. Key technologies include AI-driven screening, proteome insights, and iterative feedback loops to improve candidate quality. The company targets orphan and rare diseases and aims to shorten development timelines from years to months.

iniuva uses AI to accelerate discovery of small-molecule therapies for diseases caused by protein misfolding. It operates as an AI-powered platform for small-molecule drug discovery serving biotech and pharmaceutical companies. Key technologies include AI-driven screening, proteome insights, and iterative feedback loops to improve candidate quality. The company targets orphan and rare diseases and aims to shorten development timelines from years to months.